ArticleFrontiers in oncology

Erratum: ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer.

Frontiers Production OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.